Nuclear Medicine Practice Questions

Q: Isotope used in bone scans:

Technetium. **Technetium** - **Technetium-99m (Tc-99m)** is the most widely used isotope in bone scans due to its ideal physical characteristics, including a short half-life and suitable gamma energy for imaging. - It rapidly localizes to areas of **increased osteoblastic activity** and blood flow, making it effective for detecting bone pathologies like fractures, infections, and tumors. *Chromium* - **Chromium-51** is primarily used for **red blood cell labeling** to assess red cell mass, survival, and gastrointestinal bleeding. - It is not used for bone imaging because it does not accumulate in bone tissue and has different decay characteristics. *Selenium* - **Selenium-75** is used for imaging the **parathyroid glands** (e.g., in hyperparathyroidism) and in some studies of pancreatic function. - It does not have an affinity for bone tissue and is therefore unsuitable for bone scanning. *Gallium* - **Gallium-67** is primarily used in **inflammation and infection imaging** (Ga-67 scans) and some tumor imaging. - While it can accumulate in some bone pathologies (like osteomyelitis), it is not the primary or preferred isotope specifically for routine bone structural scans.

Q: Which imaging study is preferred for detecting a Meckel's diverticulum?

Technetium-99m pertechnetate scan. ***Technetium-99m pertechnetate scan*** - This scan specifically identifies **ectopic gastric mucosa**, which is present in over 50% of symptomatic Meckel's diverticula. - The **Technetium-99m pertechnetate tracer** is concentrated and secreted by the gastric parietal cells. *Barium enema* - A barium enema is primarily used to visualize the **large intestine** and is generally not effective for small bowel lesions like Meckel's diverticulum. - It has a very low sensitivity for detecting Meckel's diverticulum, especially if the diverticulum is small or not distended. *CT scan* - While a CT scan can sometimes show a Meckel's diverticulum, especially if it's inflamed or complicated, it is **not the preferred initial imaging modality** for uncomplicated cases. - Its sensitivity for detecting Meckel's diverticulum with ectopic gastric mucosa is lower compared to the Technetium-99m scan. *Ultrasound* - Ultrasound can be useful in detecting complications of Meckel's diverticulum, such as **inflammation or intussusception**, but it is generally not reliable for direct visualization of the diverticulum itself. - The small size and often intra-abdominal location of the diverticulum make it difficult to reliably identify with ultrasound.

Q: A 55-year-old woman with a history of breast carcinoma presents with new-onset bone pain. What is the most appropriate diagnostic test?

Bone scan. A 55-year-old woman with a history of breast carcinoma presents with new-onset bone pain. What is the most appropriate diagnostic test? ***Bone scan*** - A **bone scan** is highly sensitive for detecting **metastatic bone disease**, especially in patients with a history of cancer and new-onset bone pain. - It identifies increased osteoblastic activity around bony metastases, even when other imaging might appear normal. *MRI of the spine* - While an **MRI of the spine** is excellent for visualizing **soft tissue involvement** and spinal cord compression from metastases, it is typically used for more localized pain or neurological deficits, not as an initial broad screening tool for diffuse bone pain. - It would be beneficial if the bone pain was localized to the spine, but it does not provide a comprehensive assessment of the entire skeletal system for metastases. *CT scan of the abdomen* - A **CT scan of the abdomen** is primarily used to evaluate **abdominal organs** and detect metastases within the abdomen. - It is not the most appropriate initial test for assessing **bone pain**, as it offers limited views of bone involvement beyond the abdominal region and less sensitivity for early bone lesions compared to a bone scan. *X-ray of the affected bone* - An **X-ray of the affected bone** can detect significant lytic or blastic lesions, but it often requires **30-50% bone demineralization** before a lesion becomes visible. - X-rays are less sensitive than bone scans for detecting early metastatic disease and may miss multifocal lesions.

Q: Acute myocarditis scintigraphy is done with -

Gallium. ***Gallium*** - **Gallium-67 citrate** accumulates in areas of inflammation and infection, making it useful in detecting **active inflammatory processes** like myocarditis. - In acute myocarditis, the **inflammatory infiltrates** within the myocardium take up gallium, localizing the areas of disease. *Thallium* - **Thallium-201** is primarily used for **myocardial perfusion imaging** to assess blood flow to the heart muscle, not inflammation. - It reflects **myocyte viability** and is typically used to detect ischemia or infarction. *Technetium* - **Technetium-99m labeled tracers** (e.g., Sestamibi, Tetrofosmin) are also widely used for **myocardial perfusion imaging**. - While other **Technetium-labeled agents** can detect inflammation, these specific perfusion tracers are not the primary choice for acute myocarditis. *None of the options* - This option is incorrect because **Gallium-67 scintigraphy** is a recognized method for detecting myocardial inflammation in acute myocarditis. - Other imaging modalities like **cardiac MRI with gadolinium** are also used, but among the given options, gallium is relevant for scintigraphy.

Q: What is the appropriate dose range for MIBG in the treatment of neuroblastoma?

11.1-14.8 GBq (300-400 mCi). ***11.1-14.8 GBq (300-400 mCi)*** - This range represents the **standard high-dose MIBG therapy** commonly used for treating neuroblastoma in recurrent or refractory cases. - The precise dose is often adjusted based on patient factors like **body surface area** and tolerance, but this range is widely accepted for therapeutic efficacy. *3.7-5.5 GBq (100-150 mCi)* - This dose range is typically considered for **diagnostic MIBG scans** or for **lower-dose therapies**, not the higher therapeutic doses needed for effective neuroblastoma treatment. - Doses in this range are **insufficient** to achieve the desired cytotoxic effect on neuroblastoma cells. *7.4-11.1 GBq (200-300 mCi)* - While higher than diagnostic doses, this range is generally considered **suboptimal** for achieving significant tumor regression in advanced neuroblastoma when compared to the higher established therapeutic doses. - It may be used in specific situations, but the **maximal effective dose** is generally preferred. *5.5-7.4 GBq (150-200 mCi)* - Similar to the 7.4-11.1 GBq range, this is usually **below optimal therapeutic doses** for neuroblastoma. - This range might be explored in patients with **compromised organ function** or as a bridge therapy, but it is not the standard full therapeutic dose.

Q: Radiation used most commonly for pain management due to bone metastasis is?

Strontium-89. ***Strontium-89*** - **Strontium-89** is a **beta-emitting radiopharmaceutical** specifically approved for **palliation of painful bone metastases** - Administered **intravenously**, it preferentially localizes to areas of increased osteoblastic activity in **metastatic bone lesions** - Provides effective pain relief in **70-80% of patients** with widespread bone metastases, particularly from prostate and breast cancer - It is one of the **most commonly used** radiation modalities specifically indicated for bone metastasis pain management *Cobalt-60* - **Cobalt-60** was historically used in **external beam radiotherapy (EBRT)** teletherapy units for treating bone metastases - In modern practice, Cobalt-60 has been largely **replaced by linear accelerators (LINAC)** for EBRT - While EBRT is used for localized bone metastases, for the specific indication of widespread bone pain, radiopharmaceuticals are preferred *Iridium-192* - **Iridium-192** is primarily used in **brachytherapy** for localized tumor treatment - Not typically used for **bone metastases pain management** - More commonly employed for gynecological, prostate, and other site-specific cancers *Tritium* - **Tritium** (Hydrogen-3) is a low-energy beta-emitter used in **research and diagnostics** - Not used for **therapeutic radiation** - Its low energy and short range make it unsuitable for treating bone lesions

Q: What is the half-life of Technetium-99m?

6 hours. ***6 hours*** - The **half-life of Technetium-99m (Tc-99m)** is approximately **6 hours**, making it suitable for diagnostic imaging as it allows for sufficient time for imaging while minimizing radiation exposure. - This relatively short half-life ensures that the patient's body is exposed to **radioactivity** for a limited period. *2 hours* - A half-life of **2 hours** would be too short for many diagnostic procedures, as the radioisotope would decay too quickly to complete necessary imaging. - While some isotopes have shorter half-lives, **Technetium-99m** is specifically chosen for its optimal 6-hour half-life. *12 hours* - A half-life of **12 hours** would result in significantly increased radiation exposure to the patient, which is generally undesirable for routine diagnostic imaging. - Longer half-lives typically limit the amount of activity that can be administered safely. *24 hours* - A half-life of **24 hours** would expose the patient to an unacceptably high and prolonged dose of radiation, making it unsuitable for most diagnostic medical imaging applications. - Such long half-lives are typically reserved for therapeutic applications or specialized research, not diagnostic scans.

Q: Half life of tritium is?

12.3 years. ***12.3 years*** - The **half-life of tritium** is a well-established physical constant, representing the time it takes for half of a given sample of the radioactive isotope to decay. - This value is crucial in fields such as **radiometric dating**, **nuclear medicine**, and assessing the environmental impact of tritium. *10.2 years* - This value is **incorrect** for the half-life of tritium. - While within a similar range, it does not match the empirically determined and widely accepted value. *15.5 years* - This value is also **incorrect** for the half-life of tritium. - It is significantly longer than the known decay constant for this isotope. *20.7 years* - This value is substantially **incorrect** and much longer than the true half-life of tritium. - This duration would imply a much slower radioactive decay rate than observed.

Q: Which of the following primarily governs the uptake of Tc-99m MDP in body?

Amount of osteogenic activity. ***Amount of osteogenic activity*** - The **uptake of Tc-99m MDP** (Technetium-99m Methylene Diphosphonate) is directly proportional to the rate of **bone turnover** and **osteoblastic activity**. - MDP is a **phosphate analog** that adsorbs onto the hydroxyapatite crystals at sites of new bone formation. *Amount of iodine uptake* - **Iodine uptake** is primarily associated with the **thyroid gland** and its function in hormone synthesis, not bone metabolism. - Radioactive iodine isotopes like **I-131** or **I-123** are used for thyroid imaging and treatment, not bone scans. *Amount of calcium uptake* - While calcium is a major component of bone, the uptake of **Tc-99m MDP** is not directly governed by the amount of **calcium being deposited**. - Instead, it reflects the *rate* of crystal formation and bone matrix production, which involves osteoblastic activity. *Amount of catecholamine activity* - **Catecholamine activity** refers to the production and release of neurotransmitters like **epinephrine** and **norepinephrine**, typically associated with the **adrenal glands** and nervous system. - This has no direct relevance to the uptake mechanism of **Tc-99m MDP** in bone.

Q: Technetium-99m methylene diphosphonate is structurally similar to

Calcium phosphate. ***Calcium phosphate*** - **Technetium-99m methylene diphosphonate (Tc-99m MDP)** is a **radiopharmaceutical** used in **bone scans** because it mimics **calcium phosphate**, the main mineral component of bone. - This structural similarity allows it to incorporate into the **hydroxyapatite crystals** in bone, localizing to areas of active bone turnover. *Phosphorus* - While phosphorus is a component of MDP and bone, it is not structurally similar to **elemental phosphorus** alone. - **Elemental phosphorus** is highly reactive and not used as a clinical imaging agent. *Sodium bicarbonate* - **Sodium bicarbonate** is a salt used as an antacid or for metabolic acidosis, with no structural or physiological resemblance to bone mineral. - Its chemical structure is entirely different, involving sodium, hydrogen, carbon, and oxygen. *Magnesium sulfate* - **Magnesium sulfate** is a salt used for conditions like eclampsia or constipation, with no structural or physiological similarity to bone mineral. - Its primary role involves magnesium and sulfate ions, not the phosphate backbone critical for bone imaging.

Question 1

Isotope used in bone scans:

Accepted Answer

Technetium

Answer

Chromium

Answer

Selenium

Answer

Gallium

Question 2

Which imaging study is preferred for detecting a Meckel's diverticulum?

Accepted Answer

Technetium-99m pertechnetate scan

Answer

Barium enema

Answer

CT scan

Answer

Ultrasound

Question 3

A 55-year-old woman with a history of breast carcinoma presents with new-onset bone pain. What is the most appropriate diagnostic test?

Accepted Answer

Bone scan

Answer

MRI of the spine

Answer

CT scan of the abdomen

Answer

X-ray of the affected bone

Question 4

Acute myocarditis scintigraphy is done with -

Accepted Answer

Gallium

Answer

Thallium

Answer

Technetium

Answer

None of the options

Question 5

What is the appropriate dose range for MIBG in the treatment of neuroblastoma?

Accepted Answer

11.1-14.8 GBq (300-400 mCi)

Answer

7.4-11.1 GBq (200-300 mCi)

Answer

3.7-5.5 GBq (100-150 mCi)

Answer

5.5-7.4 GBq (150-200 mCi)

Question 6

Radiation used most commonly for pain management due to bone metastasis is?

Accepted Answer

Strontium-89

Answer

Cobalt-60

Answer

Iridium-192

Answer

Tritium

Question 7

What is the half-life of Technetium-99m?

Accepted Answer

6 hours

Answer

2 hours

Answer

12 hours

Answer

24 hours

Question 8

Half life of tritium is?

Accepted Answer

12.3 years

Answer

10.2 years

Answer

15.5 years

Answer

20.7 years

Question 9

Which of the following primarily governs the uptake of Tc-99m MDP in body?

Accepted Answer

Amount of osteogenic activity

Answer

Amount of iodine uptake

Answer

Amount of calcium uptake

Answer

Amount of catecholamine activity

Question 10

Technetium-99m methylene diphosphonate is structurally similar to

Accepted Answer

Calcium phosphate

Answer

Phosphorus

Answer

Sodium bicarbonate

Answer

Magnesium sulfate

Nuclear Medicine — MCQs

Nuclear Medicine — MCQs

On this page

Practice by Chapter

Want unlimited practice?